Entasis Therapeutics Holdings
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$47,141,000 over the previous period. Total operating expenses were $52,317,000.
Profit Margin
| 2016 | 0 | -19.09M | |
|---|---|---|---|
| 2017 | 0 | -29.92M | |
| 2018 | 5M | -32.95M | -659.04% |
| 2019 | 7M | -43.85M | -626.43% |
| 2020 | 0 | -50.49M | |
| 2021 | 0 | -47.14M |
ETTX Income Statement (2016 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 7M | 5M | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 7M | 5M | 0 | 0 |
Operating exp. | ||||||
Research and development | 37.10M | 41.02M | 40.16M | 33.04M | 25.74M | 15.77M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 52.31M | 50.66M | 51.63M | 37.87M | 31.34M | 19.10M |
Operating income | -47.14M | -54.23M | -46.93M | -38.20M | -31.34M | -19.10M |
Other income (expenses), net | 0 | 3.73M | 3.76M | 5.72M | 1.42M | 9K |
Income before tax | -47.14M | -50.49M | -43.17M | -32.48M | -29.92M | -19.09M |
Income tax expense | 0 | 3.73M | 677K | 472K | 1.42M | 9K |
Net income | -47.14M | -50.49M | -43.85M | -32.95M | -29.92M | -19.09M |
Earnings per share | ||||||
Basic EPS | -1 | -2.1 | -3.33 | -9.64 | -8.05 | -5.14 |
Diluted EPS | -1 | -2.1 | -3.33 | -9.64 | -8.05 | -5.14 |
| Data source | Data source | Data source | Data source |